Objectives of webinar:
- The attendee will discuss the evolution of EEG monitoring with respect to changes in delegation of authority in the neurocritical care unit.
- Review the pharmacologic treatment options for status epilepticus (SE) and refractory status epilepticus (RSE).
- Learn who should undergo urgent EEG for possible nonconvulsive status epilepticus, including when, why and for how long.
- Review data on the management of nonconvulsive status epilepticus.
Earn 1.5 FREE credits for MD, PharmD, and Nursing!
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. We’ve created and validated an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications. For more information contact EEG@Ceribell.com
Release Date: October 1, 2020
Expiration Date: September 30, 2021
In support of improving patient care, this activity has been planned and implemented by Cine-Med, Gladwell CME and the Neurocritical Care Society. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Cine-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Cine-Med employees, Neurocritical Care employees, and Activity Planners in control of content have indicated that they have no relevant financial relationships to disclose.
Karen Berger, PharmD, BCPS, BCCCP
Dr. Karen Berger is a neurocritical care clinical pharmacist at NewYork-Presbyterian Hospital, Weill Cornell Medical Center. She received her doctor of pharmacy from the University of Florida in 2009 and went on to complete her PGY-1 pharmacy residency at Yale-New Haven Hospital and her PGY-2 critical care residency at the University of Illinois Medical Center at Chicago, where she acted as chief resident. Dr. Berger is an active member of the American Society of Health-system Pharmacists, American College of Clinical Pharmacists, and Society of Critical Care Medicine and participates on various committees within these organizations. Within SCCM, she currently serves as the Chair for the Clinical Pharmacy and Pharmacology Section Education Committee and the Co-Vice Chair of the Adult Item Writing Committee. She has also been an active member of the New York State Council of Health-system Pharmacists, currently serving as the Chair of the Continuing Competency Committee and as the President for the NYC chapter. Dr. Berger is board certified in pharmacotherapy and critical care and serves as the co-chair of the student advisory committee at NYPH as well as a preceptor to pharmacy students and PGY-1 and critical care PGY-2 residents in the neurosciences intensive care unit.